Researchers found a commercial deworming tablet released only 10% of its drug content in dissolution testing, prompting investigation of new formulations designed to improve drug release and extend ...
(Yicai) March 9 -- The president of Peking Union Medical College Hospital has called for China to accelerate the legislation ...
Prosecutors accuse the former Istanbul mayor Ekrem Imamoglu of leading a criminal scheme. His supporters say Turkey’s ...
A red extract made from Talaromyces amestolkiae was tested in the bases of potential products, including face cream, shampoo, ...
BV100 Phase 1, single- and multiple-ascending dose clinical trial data include pharmacokinetics, safety and tolerability data. BV100 demonstrated a dose-proportional pharmacokinetic profile and was ...
A cube of healthy bone is anything but solid. Inside it, countless tiny channels carry fluid and help cells move, feed, and ...
So welcome to our second IR went in 2026, focusing this time on the Phase III ALLEGORY results for Gazyva in SLE, which just got presented last Friday at SLEuro. Today's call is scheduled for 60 ...
MIT researchers developed Attention Matching, a KV cache compaction technique that compresses LLM memory by 50x in seconds — ...
Consistency, digestibility and energy advantages of U.S. Soy translate into better growth, feed efficiency and flock ...
Rackfinity, a leader in intelligent technology, has cemented their role as a key infrastructure partner for global ...
It’s demoralizing to know the final word in a cancer treatment plan can come from a profit-driven decision made in an insurer’s office instead of a doctor.
BIDMC microbiologists unveil a faster, simpler test to predict antibiotic effectiveness against drug‑resistant infections, saving time and improving care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results